CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: This is consistent with our previous study where CLF was able to inhibit Leukemic stem cells (LSCs) via apoptosis, reduce Aldefluor activity, lower colony number, and induce apoptosis of CD34+-enriched cells in imatinib-resistant CP-CML cells.